- 期刊
Distinct Patterns of Interleukin-12/23 and Tumor Necrosis Factor α Synthesis by Activated Macrophages are Modulated by Glucose and Colon Cancer Metabolites
摘要
Chronic inflammation is a major risk factor for colitis-associated colorectal carcinoma (CRC). Macrophages play a key role in altering the tumor microenvironment by producing pro-inflammatory and anti-inflammatory cytokines. Our previous studies showed that glucose metabolism conferred death resistance for tumor progression and exerted anti-inflammatory effects in ischemic gut mucosa. However, the effect of glucose and cancer metabolites in modulating macrophage cytokine profiles remains poorly defined. We used an in vitro system to mimic intestinal microenvironment and to investigate the roles of glucose and cancer metabolites in the cross-talk between carcinoma cells and macrophages. Human monocyte-derived THP-1 macrophages were stimulated with bacterial lipopolysaccharide (LPS) in the presence of conditioned media (CM) collected from human CRC Caco-2 cells incubated in either glucose-free or glucose-containing media. Our results demonstrated that glucose modulated the macrophage cytokine production, including decreased LPS-induced pro-inflammatory cytokines (i.e., tumor necrosis factor [TNF]α and interleukin [IL]-6) and increased anti-inflammatory cytokine (i.e., IL-10), at resting state. Moreover, glucose-containing CM reduced the macrophage secretion of TNFα and IL-8 but elevated the IL-12 and IL-23 levels, showing an opposite pattern of distinct pro-inflammatory cytokines modulated by cancer glucose metabolites. In contrast, LPS-induced production of macrophage inflammatory protein-1 (a macrophage-derived chemoattractant for granulocytes) was not altered by glucose or CM, indicating that resident macrophages may play a more dominant role than infiltrating granulocytes for responding to cancer metabolites. In conclusion, glucose metabolites from CRC triggered distinct changes in the cytokine profiles in macrophages. The downregulation of death-inducing TNFα and upregulation of Th1/17-polarizing IL-12/IL-23 axis in macrophages caused by exposure to cancer-derived glucose metabolites may contribute to tumor progression.
參考文獻
延伸閱讀
- Jablonska, E. (2002). Effect of soluble interleukin-6 receptor α and interleukin-6 secreted by polymorphonuclear leukocytes on tumor necrosis factor-α expression and its production by peripheral blood mononuclear cells. Mediators of Inflammation, 2002(), 325-328. https://doi.org/10.1080/09629350210000015746
- Issekutz, A. C., Lopes, N., & Issekutz, T. B. (1992). Role of interleukin-1 and tumour necrosis factor in leukocyte recruitment to acute dermal inflammation. Mediators of Inflammation, 1992(), 347-353. https://doi.org/10.1155/S0962935192000528
- Pereira, F. O., Frode, T. S., & Medeiros, Y. S. (2006). Evaluation of Tumour Necrosis Factor Alpha, Interleukin-2 Soluble Receptor, Nitric Oxide Metabolites, and Lipids as Inflammatory Markers in Type 2 Diabetes Mellitus. Mediators of Inflammation, 2006(), 212-218. https://doi.org/10.1155/MI/2006/39062
- Ribeiro, R. A., Lucca, F. L. D., Flores, C. A., Cunha, F. Q., & Ferreira, S. H. (1992). RNA from LPS-stirnulated macrophages induces the release of tumour necrosis factor-α and interleukin-1 by resident macrophages. Mediators of Inflammation, 1993(), 435-442. https://doi.org/10.1155/S0962935193000626
- Yang, H., Li, T., Wei, J., Zhang, H., & He, S. (2013). Induction of Tumor Necrosis Factor (TNF) Release from Subtypes of T Cells by Agonists of Proteinase Activated Receptors. Mediators of Inflammation, 2013(), 273-282-025. https://doi.org/10.1155/2013/165453